Utah Medical Products, Inc. (UTMD) Q3 Rev -12% YoY; EPS +7%

Utah Medical Products, Inc. posted Q3 2026 revenue of $8.62M (-12% YoY) and diluted EPS of $0.876 (+6.8% YoY). Net income rose 5.9% to $2.79M as operating income margin improved. 2026 sales are now projected to decline ~7% for the year.Material DetailsContext by AI AnalystThis is a mid-cycle update…